Trials / Recruiting
RecruitingNCT07465705
Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY)
A Phase III, International, Multicenter, Randomized, Parallel-group, Endoscopist-blinded Non-inferiority Study of the Efficacy, Safety and Patient Acceptance of Mannitol Versus Plenvu® in Bowel Preparation for Elective Colonoscopy. CLEARWAY
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 412 (estimated)
- Sponsor
- NTC srl · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to test the non-inferiority of bowel cleansing with 100 g Mannitol against standard Plenvu® same-day dosing regimen. The 50% of the subjects will receive Mannitol, while the remaining part will receive Plenvu®.
Detailed description
Not provided
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 100g of Mannitol | Participants should self administer the preparation within 45 minutes, dissolving 100g of powder in 1L of water |
| DRUG | 1L PEG-Asc | Self administration of the same day preparation according to the on lable instruction for use. The first dose consists in dissolving Dose 1 in 500ml of water, followed by another 500ml of water, all within 1 hour. After a 1 hour wait from the end of the first dose, the participant should self administer the Dose 2 consisting in dissolving one sachetA and one sachetB in 500ml of water, followed by another 500ml of water; all within 1 hour. |
Timeline
- Start date
- 2025-09-02
- Primary completion
- 2026-03-31
- Completion
- 2026-06-30
- First posted
- 2026-03-12
- Last updated
- 2026-03-13
Locations
18 sites across 5 countries: Belgium, Italy, Poland, Spain, Sweden
Source: ClinicalTrials.gov record NCT07465705. Inclusion in this directory is not an endorsement.